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Abstract
pH-responsive polymers have been synthesised by grafting L-valine (PV-75), L-
leucine (PL-75) and L-phenylalanine (PP-75) onto the pendant carboxylic acid 
moieties of a pseudo-peptide, poly(L-lysine iso-phthalamide), at a stoichiometric
degree of substitution of 75 mol%. The effect of such modification on the pH-, 
concentration- and time-dependent cell membrane-disruptive activity of the grafted 
polymers has been investigated using a haemolysis model. At 0.025 mg mL-1, the 
grafted polymers were almost non-haemolytic at pH 7.4, but mediated considerable 
membrane lysis after 60 min in the pH range characteristic of early endosomes, which 
ranked in the order: PP-75 > PL-75 > PV-75 > poly(L-lysine iso-phthalamide). PP-75 
was 35-fold more lytic on a molar basis than the membrane-lytic peptide melittin. 
With increasing concentration, the grafted polymers showed an increased ability to 
lyse cell membranes and caused noticeable membrane disruption at physiological pH. 
The mechanism of the polymer-mediated membrane destabilisation has been 
investigated. The in-vitro cytotoxicity of the grafted polymers has been assessed using 
a propidium iodide fluorescence assay. It has been demonstrated by confocal 
microscopy that the grafted polymers can induce a significant release of endocytosed 
materials into the cytoplasm of HeLa cells, which is a feature critical for drug delivery
applications.
Keywords: pH-responsive polymer; Pseudo-peptide; Hydrophobic amino acid; 
Haemolysis; Cytotoxicity; Drug delivery
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1. Introduction
Advances in genomics and proteomics have enabled the development of 
biomacromolecular drugs (e.g. nucleic acids and proteins) with potential for the 
treatment of a wide variety of diseases [1]. Amongst other problems, their clinical 
applications may be impaired by degradation by lysosomal enzymes during uptake 
into cells [2,3]. In order to achieve efficient intracellular delivery of such drugs, 
delivery systems are required that facilitate their release into the cytoplasm by 
destabilising endosomal membranes under mildly acidic conditions (pH 5.0-6.8) [4,5].
Recombinant viruses and fusogenic viral peptides have been used to mediate gene 
transfection [6-8], but their clinical use is potentially limited by safety issues and 
difficulties in large-scale production [9,10]. A variety of synthetic polymers have 
therefore been developed as non-viral vectors. Cationic polyethyleneimine [11], 
poly(2-(dimethylamino)ethyl methacrylate) [12] and polyamidoamine dendrimers [13]
mediate gene delivery through the ‘proton sponge’ effect [14], but suffer from 
cytotoxicity and relatively low transduction efficiencies [15-17]. Anionic 
pH-responsive polymers are of interest as drug carriers because they can mimic the 
structure and pH-dependent membrane-lytic behaviour of endosomolytic viral 
peptides. The biomimetic polymers containing hydrophobic side chains and ionisable 
carboxyl groups undergo a change of conformation from extended charged chains to 
globular hydrophobic structures upon reduction of pH below their pKa ranges [18]. 
Hydrophobic interactions between the resulting hydrophobic domains and lipid 
bilayer membranes, and/or hydrogen bonding involving protonated carboxyl groups 
*Manuscript
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and lipid phosphodiester groups, lead to increased membrane binding of polymers and 
subsequent membrane disruption [19-23] through pore formation [24,25] or 
membrane solubilisation [22,26]. The hydrophobicity of polymers is one of the factors 
that influence their membrane-disruptive behaviour [23,27], and the balance between 
their hydrophobic and hydrophilic components is required to be manipulated.
Vinyl poly(Į-alkylacrylic acid) polymers can be manipulated by controlling the 
hydrophobicity of pendant alkyl groups to disrupt lipid bilayer membranes at
endosomal pH values, whilst being essentially non-lytic at physiological pH
[3,17,28,29]. This has prompted their potential applications in cytoplasmic drug 
delivery [30-33]. However, vinyl polymers are not biodegradable, thus low molecular 
weights are required to allow renal excretion [34]. A biodegradable pseudo-peptidic 
polymer, poly(L-lysine iso-phthalamide), has been developed to overcome this 
limitation [35-37], but its use is limited by low cell membrane-lytic capacity over a 
relatively low pH range (4.6-5.0) [38]. This pseudo-peptide contains a hydrophobic 
backbone and pendant carboxyl groups, without hydrophobic side chains presented in 
fusogenic peptides and poly(Į-alkylacrylic acid)s. Here, pH-responsive polymers have 
been prepared by grafting poly(L-lysine iso-phthalamide) through amide bonding with 
three different hydrophobic amino acids: L-valine, L-leucine and L-phenylalanine. The 
effects of the conjugated hydrophobic side chains on the cell membrane-disruptive 
activity and in-vitro cytotoxicity of the polymers are discussed in this paper. Their 
subcellular distributions and abilities to release endocytosed materials into the 
cytoplasm of mammalian cells are also evaluated.
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2. Materials and methods
2.1. Materials
Iso-phthaloyl chloride, potassium carbonate, N,N’-dicyclohexylcarbodiimide 
(DCC), 4-dimethylaminopyridine (DMAP), N,N-dimethylformamide (DMF), 
triethylamine, fluorescein 5-isothiocyanate (FITC), calcein, melittin ( 85%, HPLC),
mPEG-5000 and PEG-10000 were purchased from Sigma-Aldrich (Dorset, UK). 
L-lysine methyl ester dihydrochloride, disodium hydrogen phosphate, trisodium 
citrate, dimethyl sulfoxide (DMSO) and D-glucose were obtained from Fisher 
(Loughborough, UK). L-valine methyl ester hydrochloride, L-leucine methyl ester 
hydrochloride and L-phenylalanine methyl ester hydrochloride were purchased from 
Alfa Aesar (Heysham, UK). Sterile defibrinated sheep red blood cells (RBCs) were 
purchased from TCS Biosciences (Buckingham, UK). RPMI-1640 medium (without 
L-glutamine), Dulbecco’s modified Eagle medium (DMEM) and propidium iodide
were purchased from Invitrogen (Paisley, UK). Foetal bovine serum (FBS), 
Dulbecco’s phosphate buffered saline (D-PBS), penicillin-streptomycin solution
(10,000 units mL-1 penicillin and 10 mg mL-1 streptomycin), L-glutamine solution
(200 mM) and trypsin-EDTA solution (0.5 g L-1 porcine trypsin and 0.2 g L-1
EDTA·4Na) were obtained from Sigma-Aldrich (Dorset, UK).
2.2. Polymer preparation and composition determination
The synthesis of poly(L-lysine iso-phthalamide) has been reported previously 
[35-37]. L-valine, L-leucine and L-phenylalanine were grafted onto the pendant 
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carboxylic acid moieties along the backbone of poly(L-lysine iso-phthalamide) 
(designated as PV, PL and PP series polymers respectively) (Fig. 1). Full details are to 
be published elsewhere, but in summary the grafted polymers were prepared from the 
coupling reaction between poly(L-lysine iso-phthalamide) and amino acid (L-valine, 
L-leucine and L-phenylalanine) methyl ester hydrochloride in anhydrous DMSO/DMF
by DCC/DMAP mediated amide coupling chemistry [39,40] and subsequent 
hydrolysis with ethanolic sodium hydroxide. Three grafted polymers PV-75, PL-75
and PP-75 with the same stoichiometric molar percentage (75%) of amino acids 
relative to the pendant carboxylic acid groups of poly(L-lysine iso-phthalamide) are 
considered here. The structures of poly(L-lysine iso-phthalamide) and these grafted 
polymers were confirmed using a Nicolet Nexus FTIR spectrometer (Thermo Fisher 
Scientific, USA) and a Bruker Advance 500 MHz NMR spectrometer (Bruker Biospin 
GmbH, Germany). The molecular weight of poly(L-lysine iso-phthalamide) (Mw = 
35,700, Mn = 17,900, polydispersity = 1.99) was determined using an aqueous gel 
permeation chromatography (GPC) system (Viscotek, UK), which was calibrated with 
polyethylene glycol standards. The degrees of grafting of PV-75, PL-75 and PP-75 
were measured from their 1H-NMR spectra, and used to calculate their molecular 
weights. The compositions of these polymers are shown in Table 1. 
Fluorophore-labelled polymers (1.0 mol%) were prepared by coupling 
FITC-NH-(CH2)2-NH2, an amino derivative of FITC from the reaction with ethylene 
diamine using dibutyltin dilaurate as a catalyst, to the carboxylic acid groups of the
polymers using standard DCC/DMAP mediated coupling techniques. The 
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FITC-labelled polymers were purified by dialysis against deionised water and then 
lyophilised. A low level of labelling was selected here to avoid significant modulation 
of the polymer properties and fluorescence quenching.
2.3. Haemolysis assay
Membrane-lytic activity of the polymers was examined by haemolysis assay [38].
Phosphate buffers (100 mM) in the pH range of 5.0-7.4 and citrate buffers (100 mM) 
in the pH range of 4.0-5.0 were prepared to be isosmotic to the inside of an RBC and 
caused negligible haemolysis. Polymer solutions were prepared at required 
concentrations in the buffers at specific pHs and allowed to equilibrate for 48 h before 
use. Sheep RBCs were washed three times with NaCl aqueous solution (150 mM) and 
resuspended in the polymer solutions to achieve a final RBC concentration within the 
range of 1-2 × 108 RBCs mL-1. Two controls were prepared by resuspending RBCs 
either in buffer alone (negative control) or in deionised water (positive control). Each 
test was performed in triplicate. The samples were incubated in a waterbath at 37qC 
for various periods up to 2 h, and then centrifuged at 4000 rpm for 4 min. The 
absorbance of the supernatant from each sample was measured at 541 nm using a 
Spectronic UV1 spectrophotometer (Thermo Fisher Scientific, USA), and the 
percentages of haemolysis were determined. It has been demonstrated that the
absorbance of haemoglobin solution was proportional to the number of lysed RBCs 
up to a concentration of 2.64 × 108 RBCs mL-1 (data not shown).
2.4. Cell culture
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HeLa adherent epithelial cells (human cervical cancer cells) were grown in 
RPMI-1640 medium supplemented with 10% (v/v) FBS, 2 mM L-glutamine, 100 U
mL-1 penicillin and 100 ȝg mL-1 streptomycin unless specified otherwise. The HeLa 
cells were trypsinised using trypsin-EDTA and maintained in a humidified incubator 
with 5% CO2 at 37qC.
2.5. Propidium iodide fluorescence assay
The cytotoxic effect of the polymers was evaluated using a propidium iodide 
fluorescence assay [41]. 0.5 mL of HeLa cells in DMEM supplemented with 10% (v/v) 
FBS, 100 U mL-1 penicillin and 100 ȝg mL-1 streptomycin (6 × 104 cells mL-1) were 
seeded in each well of a 12-well plate (Corning, USA). After incubation for 24 h in an 
incubator at 37qC, the spent medium was replaced with 0.5 mL of fresh serum free 
DMEM containing 0.22 ȝm filter-sterilised polymer solution at the described 
concentration. These solutions were diluted from a stock polymer solution in D-PBS 
(20 mg mL-1). After 48 h, the polymer containing medium was removed, and the cells 
were rinsed with D-PBS. Subsequently, trypsin-EDTA was added at 0.5 mL per well 
to detach cells from the growth surface followed by dilution with 0.5 mL of complete 
DMEM, and the cells were centrifuged to pellet. Supernatant was aspirated and the 
cells were resuspended in 0.5 mL of D-PBS containing 1.0 ȝg mL-1 propidium iodide. 
The stained cells were incubated on ice for 30 min, and then analysed with a Vantage 
SE flow cytometer and CellQuest software (BD Biosciences, USA). Each test was
performed in triplicate.
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2.6. Subcelluar localisation of FITC-labelled polymers
2 mL of HeLa cells (1-2 × 105 cells mL-1) were seeded into a 35 mm glass-bottom 
culture dish (MatTek, USA) and cultured for 24 h in an incubator at 37qC. The spent 
medium was removed and replaced with 2 mL of serum and phenol red free medium
containing 0.22 ȝm filter-sterilised FITC-labelled polymer solution at the described
concentration. The polymer containing medium was removed after 30 min of 
incubation. The dish was washed three times with D-PBS, and replenished with serum 
and phenol red free medium. The cells were then returned to the incubator for another 
3.5 h. The images of the cells were obtained within 15 min using a FluoView™ FV300
inverted laser scanning confocal microscope (Olympus, Japan). The excitation and 
emission wavelengths were 480 and 530 nm respectively.
2.7. Release of calcein from intracellular vesicles
Calcein (a membrane-impermeable fluorophore) was used as a tracer molecule to 
monitor the effect of the polymers on internalised vesicles. 2 mL of HeLa cells (1-2 ×
105 cells mL-1) were cultured for 24 h in a 35 mm glass-bottom culture dish (MatTek, 
USA), followed by the treatment with 2 mL of serum and phenol red free medium 
containing 0.22 ȝm filter-sterilised 2.0 mg mL-1 calcein in the absence or presence of 
the polymer (these solutions were titrated to pH 7.4 using 0.1 M NaOH). After being 
incubated for 30 min at 37qC, the cells were washed three times with D-PBS and then 
incubated with serum and phenol red free medium for 3.5 h at 37qC. The distribution 
of calcein within the cells was examined within 15 min using a FluoView™ FV300
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inverted laser scanning confocal microscope (Olympus, Japan). The excitation and 
emission wavelengths were 488 and 535 nm respectively.
3. Results and discussion
3.1. Cell membrane disruption
3.1.1. pH-dependent haemolysis
The effect of grafting poly(L-lysine iso-phthalamide) with hydrophobic amino 
acids L-valine, L-leucine and L-phenylalanine on the abilities of the grafted polymers
to disrupt lipid bilayer membranes was investigated using a haemolysis model. RBC 
membranes have been selected as a model for endosomal membranes [8,17,38]. The 
relative haemolytic activity of poly(L-lysine iso-phthalamide), PV-75, PL-75 and 
PP-75 was examined as a function of pH at the low concentration of 0.025 mg mL-1
(Fig. 2). The pH range of 7.4-4.6 mimics the environment encountered during
intracellular trafficking through early endosomes, late endosomes and lysosomes [4,5]. 
As shown in Fig. 2, in the presence of poly(L-lysine iso-phthalamide) no haemolytic 
activity was detected within the pH range studied. PV-75 showed a marginal increase 
in haemolysis compared to the unmodified polymer. PL-75 and PP-75 were almost 
non-haemolytic at pH 7.4, but their haemolytic activity increased considerably with 
decreasing pH, reaching maximum degrees of haemolysis of 54 and 90% respectively 
at pH 6.5, within the pH range characteristic of early endosomes (pH 6.0-6.8) [4,5]. 
In the early endosomal pH range the ranking of haemolytic activity amongst the 
polymers was poly(L-lysine iso-phthalamide) < PV-75 < PL-75 < PP-75. This ranking 
 1 
 2 
 3 
 4 
 5 
 6 
 7 
 8 
 9 
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
61
62
63
64
65
correlates with the relative hydrophobicity and structures of L-valine, L-leucine and 
L-phenylalanine grafts. Normalised to a scale of 0 for glycine and 100 for the most 
hydrophobic amino acid among the 20 natural amino acids, the hydrophobicity 
indices of valine, leucine and phenylalanine at pH 7.0 are 76, 97 and 100 respectively
[42], which are close to those at acidic pH 2.0 (79, 100 and 92 respectively) [43]. This 
supports the observation that upon reduction of pH PL-75 and PP-75 display 
significant hydrophobic association and form more hydrophobic and compact 
structures than the parent polymer and PV-75 (data not shown). PL-75 and PP-75 with 
higher hydrophobicity could cause enhanced polymer-membrane interactions and
subsequent higher levels of membrane disruption. This is consistent with the report 
that increased peptide hydrophobicity results in stronger haemolytic activity [44]. 
Also, others have shown that the membrane-lytic activity of poly(Į-alkylacrylic acid)s 
can be modulated by changing the alkyl chain length of monomer units [45]. With an 
additional methylene unit, poly(Į-propylacrylic acid) was 15-fold more lytic than 
poly(Į-ethylacrylic acid) on a molar basis [3,17]. PP-75 was more haemolytic than 
PL-75 although L-phenylalanine has a similar hydrophobicity index to L-leucine,
which might reflect enhanced hydrophobic association resulting from ʌ-ʌ interactions 
between aromatic rings on the polymer backbone and those on the L-phenylalanine 
grafts, and between L-phenylalanine moieties. This is in agreement with the report that 
the aromatic residues in peptide structures can cause a dramatic increase in 
membrane-disruptive ability [8].
As shown in Fig. 3, at 1.0 mg mL-1, PV-75 showed slightly increased haemolytic 
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activity (23%) compared to the parent poly(L-lysine iso-phthalamide) (14%), with a 
concomitant marked increase in the pH corresponding to the maximum degree of 
haemolysis from 4.8 to 6.5 due to grafting with hydrophobic L-valine. PP-75 and 
PL-75 had a similar haemolytic profile, displaying maximum degrees of haemolysis 
(83-94%) over the pH range of 6.5-7.4. It has been similarly reported by Thomas et al.
[22] that the higher concentration of poly(Į-ethylacrylic acid) causes disruption of 
lipid bilayer membranes at a higher pH and sufficiently high polymer concentrations 
lead to complete membrane solubilisation at physiological pH. With further 
acidification, a sharp decrease in haemolytic activity occurred due to precipitation of 
PL-75 and PP-75. A similar effect has been noted for the haemolytic activity of 
poly(Į-propylacrylic acid) which decreased at pH 5.0-5.4 [45].
3.1.2. Concentration-dependent haemolysis
The relative haemolytic activity of PV-75, PL-75 and PP-75 at pH 6.5 (a very 
early stage of endosomal acidification) was determined as a function of concentration 
in comparison to melittin, a highly membrane-lytic bee venom peptide [46]. As shown
in Fig. 4, PV-75 displayed low levels of haemolysis throughout the concentration 
range tested, with a maximum of 23% at 1.0 mg mL-1. The haemolytic activity of 
PP-75, PL-75 and melittin was strongly influenced by concentration. PP-75 had no 
haemolytic effect at 5 ȝg mL-1, but exhibited a rapid increase in the degree of 
haemolysis to 90% at 25 ȝg mL-1. Complete disruption of erythrocyte membranes was 
achieved gradually by PP-75 with further increasing concentration to 200-750 ȝg
mL-1. PL-75 and melittin caused a low level of haemolysis of 12% at 5 ȝg mL-1, and 
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reached the degree of haemolysis of 90% at about 250 and 100 ȝg mL-1 respectively. 
Comparatively, PP-75 was 11-fold more efficient than PL-75 and 35-fold more 
efficient than melittin at membrane disruption on a molar basis. Thomas et al. [22] has 
reported a similar observation for the membrane-lytic activity of poly(Į-ethylacrylic 
acid) and argued that increasing polymer concentration can enhance the driving force 
for migration of polymer molecules to lipid bilayer membranes, resulting in an 
increase in membrane destabilisation.
3.1.3. Time-dependent haemolysis
The kinetics of haemolytic activity of poly(L-lysine iso-phthalamide) and PP-75 
were determined at pH 6.5. As seen in Fig. 5, only a low level of haemolysis (7%) was 
detected after incubation of RBCs with 1.0 mg mL-1 poly(L-lysine iso-phthalamide)
for 120 min. The hydrophobically modified polymer PP-75 displayed not only greater 
membrane disruption but also faster kinetics of haemolytic activity. At 0.025 mg mL-1, 
PP-75 showed haemolysis of 11% after 15 min, and then its haemolytic activity
increased significantly to a maximum of 90% after 60 min. With increasing 
concentration to 0.1 mg mL-1, PP-75 haemolysed 36% sheep RBCs after 15 min,
followed by an increase to a maximum degree of haemolysis of 94% after 60 min.
The presence of PP-75 at 1.0 mg mL-1 resulted in a high level of haemolysis of 86% 
after 15 min and almost no further haemolysis occurred thereafter. It has been noted 
similarly by Jones et al. [45] that poly(Į-propylacrylic acid) showed faster and 
enhanced disruption of vesicular membranes than poly(Į-methylacrylic acid) due to a 
higher degree of hydrophobicity. Endocytosed macromolecules have been reported to 
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be trafficked from early endosomes to lysosomes within several hours [14]. The 
significantly improved kinetics of haemolytic activity of PP-75 enables the polymer to 
disrupt endosomal membranes before the vesicular evolution from endsomes to 
lysosomes, a feature critical for potential drug delivery applications. 
3.1.4. Mechanism of cell membrane disruption
The sheep RBC count was performed using a haemocytometer to investigate the 
mechanism of haemolysis by the hydrophobically modified polymers. The 
percentages of lysed RBCs by PP-75 (0.025, 0.1 and 1.0 mg mL-1) relative to the total 
RBC number in buffer alone were determined after 1 h of incubation at pH 6.5. As 
seen in Fig. 6, the percentages of lysed RBCs are consistent with the haemolysis 
results, indicating that haemoglobin was released into the buffer after rupture of cell
membranes by PP-75. This is different from the mechanism of haemolysis by 
poly(L-lysine iso-phthalamide) grafted with 17.4 wt% hydrophilic methoxy 
polyethylene glycol (mPEG), which could release haemoglobin into the extracelluar 
medium without lysing membranes [47].
Further insight into the mechanism of cell membrane disruption was obtained by 
examining the effect of osmolytes with different molecular weights on the haemolytic 
activity of PP-75 (0.025 and 1.0 mg mL-1) at pH 6.5 (Fig. 7). D-glucose (180 Da),
mPEG-5000 (5k Da) and PEG-10000 (10k Da) were added separately to a buffered 
suspension of RBC at the concentration of 10 mM, below the range at which these 
solutes alone could induce haemolysis due to osmotic pressures. As shown in Fig. 7a, 
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both PEG-10000 and mPEG-5000 inhibited haemolysis by 0.025 mg mL-1 PP-75 
substantially, indicating that defects such as pores or channels could be formed in 
RBC membranes and haemolysis occurred as a result of osmotic swelling and rupture 
of the membranes. Low molecular weight solutes in the RBC cytosol can diffuse out 
of the RBC, whilst haemoglobin is too large to permeate through the pores or 
channels formed by PP-75. The resulting osmotic imbalance can be balanced by 
addition of high molecular weight PEG-10000 and mPEG-5000 which are unable to 
permeate through the pores or channels, leading to a marked decrease in haemolysis. 
The presence of low molecular weight D-glucose had no effect on the osmotic 
imbalance caused by the haemoglobin within the RBC cytoplasm, so no inhibition of 
the haemolytic activity was observed. It has been noted that poly(Į-ethylacrylic acid) 
[24] and GALA (an endosomolytic synthetic peptide) [8] can also create defects such 
as pores or channels in lipid bilayer membranes and lyse the membranes due to 
collapse of transmembrane potential and osmotic swelling [6,8,17]. By contrast, 
D-glucose, mPEG-5000 and PEG-10000 all had no effect on haemolysis by PP-75 at 
1.0 mg mL-1 (Fig. 7b), suggesting that membrane lysis occurred in the absence of 
osmotic cell swelling. It has been reported that poly(Į-alkylacrylic acid)s at 
sufficiently high concentrations can cause complete membrane solubilisation through 
micellisation due to extensive polymer adsorption [19,21,22]. 
3.2. In-vitro cytotoxicity
The membrane-impermeant dye, propidium iodide, can enter cells with 
compromised cellular membranes, a late sign of cell death, and binds to DNA by 
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intercalation, resulting in strong red fluorescence [41]. The cytotoxic effect of 
poly(L-lysine iso-phthalamide), PL-75 and PP-75 towards HeLa cells was evaluated 
by propidium iodide fluorescence assay. As shown in Fig. 8, HeLa cells well tolerated
poly(L-lysine iso-phthalamide), displaying viabilities of ~94% within the polymer 
concentration range of 0-2000 ȝg mL-1. PL-75 was cytotoxic at the concentration 
above 500 ȝg mL-1, with the IC50 (defined as the concentration at which 50% of cell 
growth is inhibited relative to non-treated control cells) between 1000 and 2000 ȝg
mL-1. PP-75 almost had no cytotoxic effect at the concentration  50 ȝg mL-1. With 
increasing concentration up to 2000 ȝg mL-1, PP-75 progressively decreased the 
viability of HeLa cells to 28%, with the IC50 between 250 and 500 ȝg mL-1. A similar 
concentration effect of poly(Į-ethylacrylic acid) has shown that the higher 
concentrations can drive more polymer molecules to the membrane surface regardless 
of the electrostatic repulsion effect at physiological pH and cause destabilisation of 
lipid bilayer membranes due to reorgnisation and expansion of the membranes [22]. 
The ranking of IC50 amongst the polymers was poly(L-lysine iso-phthalamide) > 
PL-75 > PP-75, indicating that at the same degree of grafting, L-phenylalanine 
derivatisation results in a more cytotoxic polymer. 
3.3. Release of endocytosed materials from intracellular vesicles
The high efficiency of the hydrophobically modified polymers in disrupting 
erythrocyte membranes within the pH range characteristic of early endosomes has 
prompted an evaluation of the ability of PP-75 to release endocytosed materials into 
the cytoplasm of HeLa cells. Fig. 9 shows the subcellular localisations of the 
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FITC-labelled poly(L-lysine iso-phthalamide) and PP-75 in HeLa cells which were 
incubated for 3.5 h after 30 min of endocytic uptake of the polymers. When HeLa 
cells were treated with 1.0 mg mL-1 FITC-labelled poly(L-lysine iso-phthalamide), a 
large number of punctate spots were observed in the cells together with a very limited 
amount of diffuse staining (Fig. 9a). This indicates that most of the parent polymer 
molecules were trapped within intracellular vesicles after being endocytosed [47]. 
Treatment of HeLa cells with 0.025 mg mL-1 FITC-labelled PP-75 led to a 
considerable amount of diffuse staining resulting from homogenous dispersion of the 
polymer in the cytoplasm after disrupting the endosomal/lysosomal membrane (Fig.
9b). Almost no punctate staining is shown in Fig. 9b, suggesting that all the 
endocytosed materials were released into the cytoplasm by PP-75 at a 40-fold lower 
concentration than the parent polymer.
Fig. 10 shows the effect of poly(L-lysine iso-phthalamide) and PP-75 on the 
release of non-conjugated calcein into the cytoplasm of HeLa cells after 30 min of 
treatment and 3.5 h of further incubation. As seen in Fig. 10a, in the absence of 
polymer, the membrane-impermeable fluorophore was restricted within intracellular 
vesicles appearing as bright punctate structures, consistent with constitutive 
endocytosis of the external medium. When the cells were treated with 1.0 mg mL-1
poly(L-lysine iso-phthalamide), a small amount of green fluorescence was released 
into the cytoplasm, whilst a large number of bright intact vesicles still existed (Fig.
10b) [47]. Uptake of 0.025 mg mL-1 PP-75 resulted in a similar calcein-release profile 
to the parent polymer at 1.0 mg mL-1, but caused stronger diffuse staining (Fig. 10c). 
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As the concentration of PP-75 was increased to 0.1 mg mL-1, uniform fluorescence 
throughout the cells was observed, with disappearance of bright punctate vesicles (Fig.
10d). The significantly efficient release of endocytosed materials into the cytoplasm 
through PP-75-mediated vesicular membrane disruption is consistent with the 
haemolysis results and indicates the potential applications of the hydrophobically 
modified polymers in cytoplasmic drug delivery. 
4. Conclusions
pH-responsive biomimetic polymers have been synthesised by grafting 
hydrophobic amino acids L-valine, L-leucine and L-phenylalanine onto the pendant 
carboxylic acid groups of poly(L-lysine iso-phthalamide) to have a range of 
membrane-lytic profiles. PV-75 (62.1 mol% L-valine) caused only a marginal increase 
in haemolytic activity compared to the parent poly(L-lysine iso-phthalamide). PL-75 
(61.2 mol% L-leucine) showed significantly higher haemolytic efficiency than PV-75. 
PP-75 (63.2 mol% L-phenylalanine) was 11-fold more efficient than PL-75 and 
35-fold more efficient than melittin at membrane disruption on a molar basis. 
Haemolysis induced by PP-75 and PL-75 was pH-dependent at 0.025 mg mL-1, being 
non-haemolytic at pH 7.4 but mediating considerable membrane disruption (90%)
after 60 min at early endosomal pH by the colloid osmotic mechanism. Sufficiently 
high concentrations (e.g. 1.0 mg mL-1) led to marked membrane destabilisation at pH 
7.4. The grafted polymers were well tolerated by HeLa cells at low concentrations, but 
displayed increasing cytotoxic effects as the concentration increased. L-phenylalanine 
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derivatisation resulted in a more cytotoxic polymer. The considerably efficient release 
of endocytosed materials into the cytoplasm of HeLa cells by PP-75 suggests its 
potential applications in cytoplasmic drug delivery.
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Table 1.  Composition measurements for poly(L-lysine iso-phthalamide)s grafted 
with L-valine, L-leucine and L-phenylalanine.
Poly(L-lysine 
iso-phthalamide) PV-75 PL-75 PP-75
[NH2]/[COOH] (%)a 0 75 75 75
DS (mol%)b 0 62.1 61.2 63.2
Weight percentage of 
amino acid grafts (wt%) 0 21.4 23.1 28.1
Mn (103) c 17.9 22.8 23.3 24.9
a Stoichiometric molar percentage of amino acids (L-valine, L-leucine and L-phenylalanine)
relative to the carboxylic acid groups along the backbone of poly(L-lysine iso-phthalamide).
b Degree of substitution, defined as the number of amino acid grafts per 100 carboxylic acid 
groups and determined by 1H-NMR in d6-DMSO at room temperature.
c Calculated based on the weight percentage of amino acid grafts (wt%) and the Mn of 
poly(L-lysine iso-phthalamide) determined by GPC.
Table 1
Figure captions
Figure 1. Repeat unit structures of poly(L-lysine iso-phthalamide)s grafted with L-valine (PV series), 
L-leucine (PL series) and L-phenylalanine (PP series).
Figure 2. Relative haemolysis of sheep RBCs as a function of pH in the presence of poly(L-lysine 
iso-phthalamide) (Ŷ), PV-75 (Ɣ), PL-75 (Ÿ) and PP-75 (ź) at .25 mg mL-1. Error bars represent 
standard deviations of three samples.
Figure 3. Relative haemolysis of sheep RBCs as a function of pH in the presence of poly(L-lysine 
iso-phthalamide) (Ŷ), PV-75 (Ɣ), PL-75 (Ÿ) and PP-75 (ź) at 1. mg mL-1. Error bars represent standard 
deviations of three samples.
Figure 4. Concentration-dependent relative haemolysis of sheep RBCs by PV-75 (Ŷ), PL-75 (Ɣ), PP-75 
(Ÿ) and melittin (ź) at pH .5. Error bars represent standard deviations of three samples.
Figure 5. Relative haemolysis of sheep RBCs at pH 6.5 as a function of incubation time in the absence of 
polymer (Ÿ) and in the presence of poly(L-lysine iso-phthalamide) (ź) at 1. mg mL-1 and PP-75 at 0.025 
(Ŷ), 0.1 (Ɣ) and 1.0 mg mL-1 (Ƈ). Error bars represent standard deviations of three samples.
Figure 6. Comparison between the percentage of lysed RBCs (column) and relative haemolysis (line) by 
PP-75 at 0.025, 0.1 and 1.0 mg mL-1. The sheep RBC count by a haemocytometer and haemolysis assay 
were performed following 1 h of incubation at pH 6.5 in a 37qC waterbath. Error bar represent standard 
deviations of three samples.
Figure 7. The effect of osmolytes on the relative haemolysis of sheep RBCs by PP-75 in PBS buffer at pH 
6.5. (a) Relative haemolysis by 0.025 mg mL-1 PP-75 in the absence and presence of 10 mM D-glucose 
Figure Captions
(180 Da), mPEG (5k Da) and PEG-10000 (10k Da); (b) relative haemolysis by 1.0 mg mL-1 PP-75 in the 
absence and presence of 10 mM D-glucose (180 Da), mPEG (5k Da) and PEG-10000 (10k Da). Error 
bars represent standard deviations of three samples.
Figure 8. Concentration-dependent viabilities of HeLa cells treated with poly(L-lysine iso-phthalamide) 
(blank), PL-75 (stippled) and PP-75 (striped) over 48 h as determined by propidium iodide fluorescence 
assay. Error bars represent standard deviations of three samples. 
Figure 9. Confocal microscopy images of HeLa cells incubated for 30 min with (a) 1.0 mg mL-1
FITC-labelled poly(L-lysine iso-phthalamide) and (b) 0.025 mg mL-1 FITC-labelled PP-75. Images were 
acquired with an Olympus FluoView™ FV300 confocal unit (×60 magnification) at 3.5 h after uptake, and 
show the subcellular distribution of FITC fluorescence.
Figure 10. Confocal microscopy images of HeLa cells showing the subcellular distribution of calcein 
fluorescence. The cells were treated with (a) 2.0 mg mL-1 calcein, (b) both 2.0 mg mL-1 calcein and 1.0 
mg mL-1 poly(L-lysine iso-phthalamide), (c) both 2.0 mg mL-1 calcein and 0.025 mg mL-1 PP-75, and (d) 
both 2.0 mg mL-1 calcein and 0.1 mg mL-1 PP-75. Images were acquired with an Olympus FluoView™
FV300 confocal unit (×60 magnification) at 3.5 h after 30 min of uptake.
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